No-Joon Song

6PUBLICATIONS
82CO-AUTHORS
Tumour immunologyMolecular targetsLiquid biopsiesNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 06, 2026
Targeting alpha-ketoglutarate starvation within the tumor-immune microenvironment rescues T cell effector function in cancer immunotherapy.

|Jul 14, 2026
Safety and Clinical Outcomes of a First-in-Human Trial of Point-of-Care Manufactured Trispecific CAR T Cells Targeting CD19, CD20, and CD22.

|Oct 03, 2025
T cell subsets of urine-derived lymphocytes (UDLs) serve as an indicator of TILs and reflect immunological sex differences in bladder cancer.

Johanna M Schafer, No-Joon Song, Tong Xiao

|Jun 18, 2025
Tumor-associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint Blockers.

No-Joon Song, Juan Xie, Kyeong Joo Jung

|Jun 18, 2025
Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype.

Joanna Pozniak, Niccolò Roda, Ewout Landeloos

|Jan 04, 2024
mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancer.

No-Joon Song, Karthik B Chakravarthy, Hyeongseon Jeon

Pageof 1

Frequent Collaborators

5 joint publications

Zihai Li

3 joint publications

Dongjun Chung

2 joint publications

Jean-Christophe Marine

2 joint publications

David P Carbone